According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 142,847,000. At the end of 2023 the company had 142,847,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.14 B | 0.66% |
2022 | 0.14 B | 7.46% |
2021 | 0.13 B | 4.29% |
2020 | 0.12 B | 29.29% |
2019 | 97.93 M | 14.7% |
2018 | 85.38 M | 2.5% |
2017 | 83.3 M | 130.88% |
2016 | 36.07 M | 11.78% |
2015 | 32.27 M | 2.42% |
2014 | 31.51 M | 506.43% |
2013 | 5.19 M | 49.41% |
2012 | 3.47 M | 0% |
2011 | 3.47 M | 27.14% |
2010 | 2.73 M | 4.19% |
2009 | 2.62 M | 23.57% |
2008 | 2.12 M | 0% |
2007 | 2.12 M | 26.04% |
2006 | 1.68 M | 1.87% |
2005 | 1.65 M | 10.57% |
2004 | 1.49 M | 1.49% |
2003 | 1.47 M | 13.14% |
2002 | 1.3 M | 31.62% |
2001 | 0.99 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | 106,300,000 | -25.58% | ๐บ๐ธ USA |
Pieris Pharmaceuticals PIRS | 98,852,000 | -30.80% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | 4,857,759 | -96.60% | ๐บ๐ธ USA |